Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665086 | SCV000789147 | uncertain significance | Propionic acidemia | 2017-01-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000665086 | SCV000932084 | uncertain significance | Propionic acidemia | 2022-07-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp722Glyfs*32) in the PCCA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 7 amino acid(s) of the PCCA protein. This variant is present in population databases (rs749875940, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with propionic acidemia (Invitae). ClinVar contains an entry for this variant (Variation ID: 550359). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000665086 | SCV004202843 | likely pathogenic | Propionic acidemia | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000665086 | SCV002094990 | uncertain significance | Propionic acidemia | 2020-07-30 | no assertion criteria provided | clinical testing |